CVS launches new brand targeting biosimilar market

is entering the biosimilar space with its new subsidiary brand Cordavis. Yahoo Finance Health Care Reporter Anjalee Khemlani breaks down what the brand entails and its impact on the company.CVS is betting big on biosimilar medicine company. The company launched a new subsidiary that will work directly with manufacturers to commercialize and co-produce biosimilar medicines. Yahoo Finance's Anjalee khemlani has the details.

And then they have unbranded or unlabeled products. And that's where CVS comes in. So for this partnership, they're going to be basically putting their brand label on Sandoz's biosimilar. And that's the strategy that they're going to be employing with other companies. We have heard from some analysts who are taking a look at what is going on saying that the CVS is largely seeing this as a margin positive for the company and, quote,"that they anticipate is, like I said, margin positive but too early to tell if there's going to be really significant contribution for this." We don't yet know what that uptake is of these biosimilars.I did get a chance to talk to EVP Prem Shah. And he told me that they are looking at the supply chain as well.

México Últimas Noticias, México Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

CVS launches unit to market and co-produce biosimilars(Reuters) - CVS Health Corp said on Wednesday it has launched Cordavis, a unit that will work directly with manufacturers to commercialize and ...
Fuente: SaltWire Network - 🏆 45. / 63 Leer más »

CVS launches unit to market and co-produce biosimilars(Reuters) - CVS Health Corp said on Wednesday it has launched Cordavis, a unit that will work directly with manufacturers to commercialize and ...
Fuente: SaltWire Network - 🏆 45. / 63 Leer más »

Health care stocks: What the market technicals showWhy are UnitedHealth (UNH), Merck & Company (MRK), Johnson & Johnson (JNJ), and Amgen (AMGN), this strategist's top health care stock picks? Freedom Capital Markets Chief Global Strategist Jay Woods joins Yahoo Finance Live to discuss and break down the market technicals of health care stocks.  Woods says he focuses on those four health care stocks, 'because they're in Dow Jones Industrial Average. If you're looking for reasons why the Dow can rally, I give you health care.'  The Health Care Select Sector (XLV) 'continues to make higher lows, as it goes along,' Woods notes. 'If you're a little skittish on the overall market, health care is a safety sector,' Woods says. 
Fuente: YahooFinanceCA - 🏆 47. / 63 Leer más »